Literature DB >> 18024883

The value of label recommendations: how to dose lapatinib.

Kevin M Koch, Andrew P Beelen, Peter T C Ho, Debasish F Roychowdhury.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18024883     DOI： 10.1200/JCO.2007.13.8644

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

Review 1.  Metabolism considerations for kinase inhibitors in cancer treatment.

Authors:  Derek R Duckett; Michael D Cameron
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-10       Impact factor: 4.481

2.  A phase I and pharmacokinetic study of oral lapatinib administered once or twice daily in patients with solid malignancies.

Authors:  Howard A Burris; Charles W Taylor; Suzanne F Jones; Kevin M Koch; Melissa J Versola; Niki Arya; Ronald A Fleming; Deborah A Smith; Lini Pandite; Neil Spector; George Wilding
Journal:  Clin Cancer Res       Date:  2009-10-13       Impact factor: 12.531
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.